MSKCC in the News: March 24 – April 8

  • Memorial Sloan-Kettering Cancer Center in Commack recently unveiled a new body imaging device, known as a PET/CT scanner.  Not too many other cancer treatment centers on Long Island carry this scanner.
  • Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time (known as PSA velocity) is a poor predictor of prostate cancer and may lead to many unnecessary biopsies. Andrew Vickers, PhD, Associate Attending Research Methodologist in the Department of Epidemiology and Biostatistics and Peter T. Scardino, MD, Chair of the Department of Surgery are quoted in this article.
  • New Research and Training Grants Awarded By American Cancer Society Emily Tonorezos, MD MPH at Memorial Sloan-Kettering Cancer Center received a career development award that will give her the time and the tools to investigate diet and insulin resistance in survivors of childhood cancer. (Cancer Survivorship Grant)
  • MRI Found to Improve Breast Cancer Detection Rate. Janice S. Sung, MD, from the Memorial Sloan-Kettering Cancer Center in New York City, and colleagues evaluated the utility of MR imaging in detection of breast cancer in 91 women with a history of chest irradiation.